×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Day 2 - Session 5: Orphan Drug Regulation
Session Chair(s)
Shekhar Natarajan
Head-International Regulatory Strategy
Shire, United Kingdom, United Kingdom
Speaker(s)
Session 5.1: Orphan Drug Regulation - Brief Overview on OD Regulation in US/EU and Other Developed Markets
Shekhar Natarajan
Shire, United Kingdom, United Kingdom
Head-International Regulatory Strategy
Session 5.2: Orphan drug regulation & Rare disease policy formulation in India: Current status & expectations
Parameshwaran Sitaram
Sanofi Genzyme, India, India
Head -Market Development & Government Affairs
Session 5.3: Rare disease registry
Bhasker Sonowal
Shire, India, India
Head of External Affairs
Have an account?